SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001654954-19-014235
Filing Date
2019-12-26
Accepted
2019-12-26 16:15:41
Documents
4
Period of Report
2019-12-19
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ndra_8k.htm 8-K 45777
2 INSTRUMENTS DEFINING THE RIGHTS OF SECURITY HOLDERS, INCLUDING INDENTURES INSTRU ndra_ex41.htm EX-4.1 55342
3 INSTRUMENTS DEFINING THE RIGHTS OF SECURITY HOLDERS, INCLUDING INDENTURES INSTRU ndra_ex42.htm EX-4.2 91077
4 FORM OF SECURITIES PURCHASE AGREEMENT, DATED DECEMBER 19, 2019 ndra_ex101.htm EX-10.1 205884
  Complete submission text file 0001654954-19-014235.txt   399538
Mailing Address 3600 GREEN COURT SUITE 350 ANN ARBOR MI 48105
Business Address 3600 GREEN COURT SUITE 350 ANN ARBOR MI 48105 734-335-0468
ENDRA Life Sciences Inc. (Filer) CIK: 0001681682 (see all company filings)

IRS No.: 260579295 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37969 | Film No.: 191310723
SIC: 3845 Electromedical & Electrotherapeutic Apparatus